Histamine involvement in UVB- and cis-urocanic acid-induced systemic suppression of contact hypersensitivity responses

被引:68
作者
Hart, PH [1 ]
Jaksic, A [1 ]
Swift, G [1 ]
Norval, M [1 ]
ElGhorr, AA [1 ]
FinlayJones, JJ [1 ]
机构
[1] UNIV EDINBURGH, SCH MED, DEPT MED MICROBIOL, EDINBURGH EH8 9AG, MIDLOTHIAN, SCOTLAND
关键词
D O I
10.1046/j.1365-2567.1997.00284.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Studies in experimental models have implicated histamine and prostanoids in ultra-violet B (UVB)- and cis-urocanic acid (UCA)-induced systemic immunosuppression. This study examined the hypothesis that WE irradiation and cis-UCA suppressed contact hypersensitivity responses to hapten by induction of histamine, which in turn evoked a prostanoid-dependent component of immunosuppression. BALB/c mice were administered with a cis-UCA monoclonal antibody, a combination of histamine types I and 2 receptor antagonists, or indomethacin. Mice were sensitized to 2,4,6-trinitrochlorobenzene (TNCB) on their ventral surface 5 days after UVB irradiation, or cis-UCA or histamine administration. Ears were challenged with TNCB 5 days later. Cis-UCA antibody inhibited the suppressive effects of UVB by approximately 60% and confirmed that suppression of contact hypersensitivity responses by UVB was due, at least in part, to mechanisms involving cis-UCA. Histamine suppressed contact hypersensitivity responses and the effects of cis-UCA and histamine were not cumulative, suggesting that cis-UCA and histamine signal largely through the same pathway. The immunosuppressive effects of histamine were not affected by the cis-UCA antibody, consistent with the model that histamine acts downstream of cis-UCA. Administration of histamine receptor antagonists and indomethacin each approximately halved the UVB- and cis-UCA-induced systemic suppression of contact hypersensitivity responses. The effects of the reagents that inhibited the action of histamine and prevented prostanoid production were not cumulative, and suggested involvement in the same pathway. These results support the involvement of cis-UCA, histamine and prostanoids, in a sequence, in UVB-induced systemic suppression of contact hypersensitivity responses.
引用
收藏
页码:601 / 608
页数:8
相关论文
共 34 条
[1]   INDOMETHACIN INHIBITS THE CHEMICAL CARCINOGEN BENZO(A)PYRENE BUT NOT DIMETHYLBENZ(A)ANTHRACENE FROM ALTERING LANGERHANS CELL DISTRIBUTION AND MORPHOLOGY [J].
ANDREWS, FJ ;
HALLIDAY, GM ;
NARKOWICZ, CK ;
MULLER, HK .
BRITISH JOURNAL OF DERMATOLOGY, 1991, 124 (01) :29-36
[2]   IDENTIFICATION OF THE MOLECULAR TARGET FOR THE SUPPRESSION OF CONTACT HYPERSENSITIVITY BY ULTRAVIOLET-RADIATION [J].
APPLEGATE, LA ;
LEY, RD ;
ALCALAY, J ;
KRIPKE, ML .
JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 170 (04) :1117-1131
[3]   TRANSMISSION OF HUMAN-EPIDERMIS AND STRATUM-CORNEUM AS A FUNCTION OF THICKNESS IN THE ULTRAVIOLET AND VISIBLE WAVELENGTHS [J].
BRULS, WAG ;
SLAPER, H ;
VANDERLEUN, JC ;
BERRENS, L .
PHOTOCHEMISTRY AND PHOTOBIOLOGY, 1984, 40 (04) :485-494
[4]  
CHUNG HT, 1986, J IMMUNOL, V137, P2478
[5]  
DEFABO E, 1983, J INVEST DERMATOL, V80, P319
[6]   MECHANISM OF IMMUNE SUPPRESSION BY ULTRAVIOLET-IRRADIATION INVIVO .1. EVIDENCE FOR THE EXISTENCE OF A UNIQUE PHOTORECEPTOR IN SKIN AND ITS ROLE IN PHOTOIMMUNOLOGY [J].
DEFABO, EC ;
NOONAN, FP .
JOURNAL OF EXPERIMENTAL MEDICINE, 1983, 158 (01) :84-98
[7]   A MONOCLONAL-ANTIBODY TO CIS-UROCANIC ACID PREVENTS THE ULTRAVIOLET-INDUCED CHANGES IN LANGERHANS CELLS AND DELAYED-HYPERSENSITIVITY RESPONSES IN MICE, ALTHOUGH NOT PREVENTING DENDRITIC CELL ACCUMULATION IN LYMPH-NODES DRAINING THE SITE OF IRRADIATION AND CONTACT HYPERSENSITIVITY RESPONSES [J].
ELGHORR, AA ;
NORVAL, M .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1995, 105 (02) :264-268
[8]   AN EXAMINATION OF DIFFERENCES IN SERUM ANTIBODY SPECIFICITIES AND HYPERSENSITIVITY REACTIONS AS CONTRIBUTING FACTORS TO CHRONIC INFECTION WITH THE INTESTINAL PROTOZOAN PARASITE, GIARDIA-MURIS, IN MICE [J].
ERLICH, JH ;
ANDERS, RF ;
ROBERTSTHOMSON, IC ;
SCHRADER, JW ;
MITCHELL, GF .
AUSTRALIAN JOURNAL OF EXPERIMENTAL BIOLOGY AND MEDICAL SCIENCE, 1983, 61 (OCT) :599-615
[9]  
GOODWIN JS, 1991, J RHEUMATOL, V18, P26
[10]  
HART PH, 1993, J IMMUNOL, V150, P4514